Next 10 |
2024-10-18 09:01:17 ET Kintara Therapeutics Inc (KTRA) announced stock split at a ratio of 1-for-35 on 2024-10-18 ... Full story available on KlickAnalytics.com
Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024 PR Newswire SAN DIEGO , Oct. 16, 2024 /PRNewswire/ -- Kintara Therap...
Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences PR Newswire SAN DIEGO , Oct. 16, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. ("Kintara") (NASDAQ: KTRA), a biopharmaceutical compan...
Kintara Therapeutics Announces Correction to Prior Announcement Regarding CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 PR Newswire SAN DIEGO , Oct. 15, 2024 /PRNewswire/ -- Kintara Therapeu...
2024-10-14 13:48:50 ET More on Kintara Therapeutics Financial information for Kintara Therapeutics Read the full article on Seeking Alpha For further details see: Kintara stock climbs 10% on TuHURA merger update
Kintara Therapeutics Announces Record Date for CVR Issuance in Connection with the Proposed Merger with TuHURA Biosciences Expected to Close on October 18, 2024 PR Newswire SAN DIEGO , Oct. 14, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. ("Kintara") (Nas...
Kintara Therapeutics Announces Fiscal 2024 Financial Results and Provides Corporate Update PR Newswire SAN DIEGO , Oct. 8, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the ...
A look at the top 10 most actives in the United States Fangdd Network Group Ltd. (DUO) rose 86.7% to $0.9336 on volume of 48,474,196 shares NVIDIA Corporation (NVDA) rose 2.7% to $126.885 on volume of 47,687,904 shares SaverOne 2014 Ltd. (SVRE) rose 9.8% to $0.1712 on volume of 44,549,524 s...
Kintara Therapeutics Announces Adjournment of Special Meeting of Stockholders until October 4, 2024 PR Newswire SAN DIEGO , Sept. 20, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutical company focused on the developmen...
Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences PR Newswire Stockholders must vote by 11:59 p.m. ET on September 19, 2024 for their vote to count A "FOR" vote on Proposals 3 ...
News, Short Squeeze, Breakout and More Instantly...
Kintara Therapeutics Inc Com Company Name:
KTRA Stock Symbol:
NASDAQ Market:
-9.38% G/L:
$0.2154 Last:
3,700,222 Volume:
$0.2356 Open:
$0.2154 Close:
Kintara Therapeutics Inc Com Website:
2024-10-18 09:01:17 ET Kintara Therapeutics Inc (KTRA) announced stock split at a ratio of 1-for-35 on 2024-10-18 ... Full story available on KlickAnalytics.com
Kintara Therapeutics Announces Correction to Prior Announcement Regarding 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences to Close on October 18, 2024 PR Newswire SAN DIEGO , Oct. 16, 2024 /PRNewswire/ -- Kintara Therap...
Kintara Therapeutics Announces 1-for-35 Reverse Stock Split in Connection with the Proposed Merger with TuHURA Biosciences PR Newswire SAN DIEGO , Oct. 16, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. ("Kintara") (NASDAQ: KTRA), a biopharmaceutical compan...